Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
- Bachelot, T.
- Ciruelos, E.
- Schneeweiss, A.
- Puglisi, F.
- Peretz-Yablonski, T.
- Bondarenko, I.
- Paluch-Shimon, S.
- Wardley, A.
- Merot, J.-L.
- Du Toit, Y.
- Easton, V.
- Lindegger, N.
- Miles, D.
ISSN: 1569-8041, 0923-7534
Argitalpen urtea: 2019
Alea: 30
Zenbakia: 5
Orrialdeak: 766-773
Mota: Artikulua